Purpose Biologics have proven to be essential therapeutic agents in immune-mediated systemic diseases. Ophthalmologic adverse effects have been reported in the use of more traditional agents, such as TNF-α inhibitors, but there are limited data on ocular side effects associated with the newer generation of biologics. Observations In this report, we present a case of a suspected ustekinumab-associated recurrent sclerouveitis. Conclusions To the best of our knowledge, this is the first reported case of this type seen with ustekinumab injections. Our goal is to add to the existing literature in order to better understand the mechanism and management of this condition.

Factors associated with the use of 360-degree laser retinopexy during primary vitrectomy with or without scleral buckle for rhegmatogenous retinal detachment and impact on surgical outcomes (pro study report number 4). Retina 2019;40:2070-2076. 3. Dirani A, Antaki F, Rhéaume MA, et al. 360-degree intraoperative laser retinopexy for the prevention of retinal redetachment in patients treated with primary pars plana vitrectomy.